Dr Deborah Stocken
Helen Mossop
| Good Statistical Practice—development of tailored Good Clinical Practice training for statisticians | 2024 |
|
Dr Stefan Siebert
Dr Arthur Pratt
Dr Deborah Stocken
Dr Miranda Patterson
Amy Cranston
et al. | Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial | 2020 |
|
Professor Vinidh Paleri
Dr Joanne Patterson
Dr Nicolette Rousseau
Eoin Moloney
Professor Dawn Craig
et al. | Gastrostomy versus nasogastric tube feeding forchemoradiation patients with head and neck cancer:the TUBE pilot RCT | 2018 |
|
Professor Stuart McPherson
Dr Nina Wilson
Dr Dina Tiniakos
Dr Jennifer Wilkinson
Professor Alastair Burt
et al. | A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis | 2017 |
|
Dr Henry Grantham
Dr Deborah Stocken
Professor Nick Reynolds
| Doxycycline: A first-line treatment for bullous pemphigoid? | 2017 |
|
Dr Nigel Camilleri
Professor Dorothy Newbury-Birch
Dr Paul McArdle
Dr Deborah Stocken
Professor Ann Le Couteur
et al. | Innovations in Practice: A case control and follow-up study of "hard to reach' young people who suffered from multiple complex mental disorders | 2017 |
|
Amy Cranston
Dr Deborah Stocken
Elaine Stamp
Professor Ruth Plummer
Professor Sir John Burn
et al. | Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial. | 2017 |
|
Dr Lorraine McSweeney
James O'Hara
Dr Nicolette Rousseau
Dr Deborah Stocken
Professor Luke Vale
et al. | ‘Thinking that somebody's going to delay [a tonsillectomy] for one to two years is quite horrifying really’: a qualitative feasibility study for the NAtional Trial of Tonsillectomy IN Adults (NATTINA Part 2) | 2016 |
|
Professor Vinidh Paleri
Dr Joanne Patterson
Dr Deborah Stocken
Mike Cole
Professor Luke Vale
et al. | A feasibility study incorporating a pilot randomised controlled trial of oral feeding plus pre-treatment gastrostomy tube versus oral feeding plus as-needed nasogastric tube feeding in patients undergoing chemoradiation for head and neck cancer (TUBE trial): study protocol | 2016 |
|
Dr Deborah Stocken
| Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study | 2016 |
|
Dr Stuart Little
Dr Thomas Chadwick
Dr Deborah Stocken
Catherine Brennand
Emerita Professor Sally Marshall
et al. | Recovery of hypoglycemia awareness in longstanding type 1 diabetes: A multicenter 2×2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose selfmonitoring (HypoCOMPaSS) | 2016 |
|
Dr Jess Dyson
Dr Nina Wilson
Dr Laura Jopson
Samantha Ducker
Dr Deborah Stocken
et al. | The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis | 2016 |
|
Gillian Watson
James O'Hara
Professor Paul Carding
Jan Lecouturier
Dr Deborah Stocken
et al. | TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial | 2016 |
|
Professor Peter Farr
Professor Nick Reynolds
Dr Deborah Stocken
Claire Macdonald
Dr Shyamal Wahie
et al. | An observer-blinded randomized controlled pilot study comparing localised psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of hand eczema | 2015 |
|
Dr Jean Adams
Louis Goffe
Professor Ashley Adamson
Joel Halligan
Dr Nicola O'Brien
et al. | Prevalence and socio-demographic correlates of cooking skills in UK adults: cross-sectional analysis of data from the UK National Diet and Nutrition Survey | 2015 |
|
Dr Deborah Stocken
| REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial | 2015 |
|
Isabel Rubie
Dr Katie Haighton
James O'Hara
Dr Nicolette Rousseau
Dr Nick Steen
et al. | The NAtional randomised controlled Trial of Tonsillectomy IN Adults (NATTINA): a clinical and cost-effectiveness study: study protocol for a randomised control trial | 2015 |
|
Dr Deborah Stocken
Dr Kate Sumpter
| Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study | 2014 |
|
Dr Stuart Little
Dr Thomas Chadwick
Dr Deborah Stocken
Catherine Brennand
Emerita Professor Sally Marshall
et al. | Recovery of Hypoglycemia Awareness in Long-Standing Type 1 diabetes: A Multicenter 2x2 Factorial Randomized Controlled Trial Comparing Insulin Pump with Multiple Daily Injections and Continuous with Conventional Glucose Self-Monitoring (HypoCOMPaSS) | 2014 |
|
Dr Stuart Little
Dr Thomas Chadwick
Dr Deborah Stocken
Catherine Brennand
Emerita Professor Sally Marshall
et al. | Response to Comment on Little et al. Recovery of Hypoglycemia Awareness in Long-standing Type 1 Diabetes: A Multicenter 2 x 2 Factorial Randomized Controlled Trial Comparing Insulin Pump With Multiple Daily Injections and Continuous With Conventional Glucose Self-monitoring (HypoCOMPaSS). Diabetes Care 2014;37:2114-2122 | 2014 |
|
Dr Deborah Stocken
| Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial | 2013 |
|
Dr Deborah Stocken
| Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial | 2013 |
|
Dr Deborah Stocken
| Phase 1 trial of Recombinant Modified Vaccinia Ankara Encoding Epstein-Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients | 2013 |
|
Dr Deborah Stocken
| A Randomised Controlled Trial to Evaluate both the Role and the Optimal Fractionation of Radiotherapy in the Conservative Management of Early Breast Cancer | 2012 |
|
Richard Charnley
Dr Deborah Stocken
| Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma. The ESPAC-3 Periampullary Cancer Randomized Trial | 2012 |
|
Dr Deborah Stocken
Dr Thamir Ismail
| Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test | 2012 |
|
Dr Deborah Stocken
| The value of source data verification in a cancer clinical trial | 2012 |
|
Dr Deborah Stocken
| Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13 | 2011 |
|
Dr Deborah Stocken
| Adjuvant Chemotherapy with Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection: a Randomized Controlled Trial | 2010 |
|
Dr Deborah Stocken
| Statistical Modelling for the Prognostic Classification of Patients with Pancreatic Cancer for Optimisation of Treatment Allocation [PhD Thesis] | 2010 |
|
Dr Deborah Stocken
| Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials | 2009 |
|
Dr Deborah Stocken
| ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma | 2009 |
|
Dr Thamir Ismail
Dr Deborah Stocken
| Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme | 2009 |
|
Dr Deborah Stocken
| Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer - subset analysis of the ESPAC-1 data | 2009 |
|
Dr Deborah Stocken
| Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer | 2009 |
|
Dr Deborah Stocken
| Influence of Resection Margins and Treatment on Survival in Patients With Pancreatic Cancer: Meta-analysis of Randomized Controlled Trials | 2008 |
|
Dr Deborah Stocken
| Modelling prognostic factors in advanced pancreatic cancer | 2008 |
|
Dr Deborah Stocken
| A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin | 2007 |
|
Dr Deborah Stocken
Dr Thamir Ismail
| Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients | 2007 |
|
Dr Deborah Stocken
| The case for adjuvant chemotherapy in pancreatic cancer | 2006 |
|
Dr Deborah Stocken
| Cationic Trypsinogen Mutations and Pancreatitis | 2005 |
|
Dr Deborah Stocken
| Influence of Surgical Resection and Post-Operative Complications on Survival following Adjuvant Treatment for Pancreatic Cancer in the ESPAC-1 Randomized Controlled Trial | 2005 |
|
Dr Deborah Stocken
| Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer | 2005 |
|
Dr Deborah Stocken
| A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer | 2004 |
|
Dr Deborah Stocken
| A randomized phase II trial of neoadjuvant chemotherapy for patients with resectable pancreatic cancer: Gemcitabine alone vs. gemcitabine combined with cisplatin | 2004 |
|
Dr Deborah Stocken
| A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer | 2004 |
|
Dr Deborah Stocken
| Cationic trypsinogen mutations and pancreatitis | 2004 |
|
Dr Deborah Stocken
| Clinical and genetic characteristics of hereditary pancreatitis in Europe | 2004 |
|
Dr Deborah Stocken
| ESPAC-1: final results of a European, randomized controlled trial to assess the roles of adjuvant chemotherapy and adjuvant chemoradiation in resectable pancreatic cancer | 2004 |
|
Dr Deborah Stocken
| Long-term results of a phase II study of synchronous chemo radiotherapy in muscle invasive bladder cancer | 2004 |
|
Dr Deborah Stocken
| Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer | 2004 |
|
Dr Deborah Stocken
| The commercialisation of clinical research: who pays the piper, calls the tune? | 2004 |
|
Dr Deborah Stocken
| A phase II irinotecan–cisplatin combination in advanced pancreatic cancer | 2003 |
|
Dr Deborah Stocken
| Adjuvant therapy in pancreatic cancer: historical and current perspectives | 2003 |
|
Dr Deborah Stocken
| Adjuvante und additive therapie beim pankreaskarzinom [Adjuvant and additive therapy for cancer of the pancreas] | 2003 |
|
Dr Deborah Stocken
| Preoperative Mitomycin, Ifosfamide, and Cisplatin Followed by Esophagectomy in Squamous Cell Carcinoma of the Esophagus: Pathologic Complete Response Induced by Chemotherapy Leads to Long-Term Survival | 2003 |
|
Dr Deborah Stocken
| Influence of resection margins on survival for patients with resectable pancreatic cancer treated with chemoradiation or chemotherapy within the European Study Group for Pancreatic Cancer 1 study | 2002 |
|
Dr Deborah Stocken
| Influence of the type of surgery and surgical complications in the ESPAC-1 adjuvant trial | 2002 |
|
Dr Deborah Stocken
| A phase I—II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer | 2001 |
|
Dr Deborah Stocken
| Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial | 2001 |
|
Dr Deborah Stocken
| Combined Results from Three Phase II Trials of Neoadjuvant Chemotherapy in Operable Adenocarcinoma of the Oesophagus | 2001 |
|
Dr Deborah Stocken
| Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial | 2001 |
|
Dr Stephanie Needham
Dr Deborah Stocken
| Laparoscopic peritoneal lavage in staging gastric and oesophageal cancer | 2001 |
|
Amanda Gee
Dr Deborah Stocken
| A randomised controlled trial to test a non-metallic deodorant used during a course of radiotherapy | 2000 |
|
Dr Deborah Stocken
| Management guidelines for women with normal colposcopy after low grade cervical abnormalities: population study | 2000 |
|
Dr Deborah Stocken
| Histologic and Immunologic Associations of an HPV16 Variant in LoSIL Smears | 1999 |
|
Dr Deborah Stocken
| Adjuvant radiotherapy and follow-on chemotherapy in patients with pancreatic cancer. Results of the UK Pancreatic Cancer Group Study (UKPACA-1) | 1998 |
|
